YONGAN PHARMACEUTICAL(002365.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
YONGAN PHARMACEUTICAL
002365.SZ
Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces ethylene oxide, polycarboxylic acid-based water reducer monomers, water reducers, and health products. The company engages in scientific research and technical service, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming.
2.805 T
002365.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking151/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE1.74%C
    • Profit Margin4.08%C
    • Gross Margin20.23%D
  • Growth ScoreC
    • Revenue YoY4.25%C
    • Net Profit YoY20.47%B
    • Total Assets YoY-2.68%D
    • Net Assets YoY-1.45%D
  • Cash ScoreB
    • Cash Flow Margin326.47%A
    • OCF YoY4.25%C
  • Operating ScoreC
    • Turnover0.38C
  • Debt ScoreA
    • Gearing Ratio9.32%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    YONGAN PHARMACEUTICAL released its performance for the first three quarters, with a net profit attributable to the parent company of 25.4963 million yuan, a year-on-year decrease of 58.78%

    Zhitong·
    SZ
    002365
    -1.95%
    Zhitong·
    SZ
    002365
    -1.95%

    YONGAN PHARMACEUTICAL: Net profit for the third quarter was 13.0005 million yuan, a year-on-year increase of 38.75%

    Zhitong·
    SZ
    002365
    -1.95%
    Zhitong·
    SZ
    002365
    -1.95%

    YONGAN PHARMACEUTICAL: Plans to acquire minority shareholder equity in its controlling subsidiary for 27 million yuan

    Zhitong·
    SZ
    002365
    -1.95%
    Zhitong·
    SZ
    002365
    -1.95%

    YONGAN PHARMACEUTICAL: Controlling shareholder reduces holdings by 410,000 shares

    Zhitong·
    SZ
    002365
    -1.95%
    Zhitong·
    SZ
    002365
    -1.95%

    YONGAN PHARMACEUTICAL's actual controller Chen Yong lifts the lien

    Zhitong·
    SZ
    002365
    -1.95%
    Zhitong·
    SZ
    002365
    -1.95%
    © 2026 Longbridge｜Disclaimer